Ken Griffin Prime Medicine, Inc. Transaction History

Citadel Advisors LLC

$618 Billion
Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 900,142 shares of PRME stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

900,142

Previous 521,508 72.6%

Holding current value

$3.03 Million

Previous $1.29 Million 287.11%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$2.73 - $5.56 $1.03 Million - $2.11 Million	378,634 Added 72.6%	900,142 $4.99 Million
Q2 2025 Aug 14, 2025	BUY	$1.15 - $2.65 $599,734 - $1.38 Million	521,508 New	521,508 $1.29 Million
Q3 2024 Nov 14, 2024	BUY	$3.41 - $6.7 $130,497 - $256,402	38,269 Added 300.72%	50,995 $197,000
Q2 2024 Aug 14, 2024	SELL	$4.3 - $8.03 $410,529 - $766,640	-95,472 Reduced 88.24%	12,726 $65,000
Q1 2024 May 15, 2024	BUY	$6.35 - $9.39 $687,057 - $1.02 Million	108,198 New	108,198 $757,000

Q3 2023 Nov 14, 2023	BUY	$9.5 - $15.07 $61,978 - $98,316	6,524 New	6,524 $62,000

Others Institutions Holding PRME

# of Institutions

177

Shares Held

89M

Call Options Held

1.32M

Put Options Held

931K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $323M

More about PRME

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account